San Diego-based Forge Therapeutics, Inc., a biotechnology company discovering first-in-class antibiotics using a breakthrough drug discovery platform, recently announced a significant collaboration with CARB-X, (Combating Antibiotic Resistant Bacteria Accelerator), the world’s largest public-private partnership focused on funding the advancement of Gram-negative antibiotics. CARB-X selected Forge from a group of 168 international companies and research groups to […]